Skip to main content

Table 1 Socio-demographic and clinical characteristics of the misdiagnosed and accurately diagnosed groups: unadjusted comparisons

From: Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database

 

Misdiagnosed N = 88

Accurately diagnosed N = 438

Parameter estimate

Unadjusted OR (95% CI)

p value

Sociodemographic characteristics

     

Age, Mean ± SD

83.52 ± 10.31

78.72 ± 10.27

-4.80

 

<.0001

Years of education, Mean ± SD

14.53 ± 3.56

14.90 ± 3.34

0.37

 

.3528

Gender, N,% male

52, 59.09

254, 57.99

 

0.96 (0.60, 1.52)

.8490

Race, N,% minority

5, 5.68

24, 5.48

 

0.96 (0.36, 2.59)

.9388

Race

    

.

White, N/%

83, 94.32

414, 94.52

 

(Ref)

 

Black, N/%

3, 3.41

17, 3.88

 

1.14 (0.33, 3.97)

.8414

Asian, N/%

1, 1.14

4, 0.91

 

0.80 (0.09, 7.27)

.8444

Other, N/%

1, 1.14

3, 0.68

 

0.60 (0.06, 5.85)

.6614

Unknown, N,%

     

Marital status, married/living as married, N,%

50, 56.82

311, 71.00

 

1.86 (1.16, 2.98)

.0095

Living alone, N,%

15, 17.05

18, 4.11

 

0.21 (0.10, 0.43)

<.0001

Health history and conditions

     

Family history of dementia

     

Number of “Other demented relatives,” Mean ± SD

0.41 ± 0.80

0.63 ± 1.20

0.22

 

.1971

Father or mother with dementia, N,%

23, 32.86

183, 47.78

 

1.87 (1.09, 3.20)

.0225

Any sibling with dementia, N,%

4, 4.55

8, 1.83

 

0.39 (0.12, 1.33)

.1339

Health history

     

Cardiovascular condition, N,%

41, 47.13

137, 31.49

 

0.52 (0.32, 0.82)

.0055

Cerebrovascular condition N,%

18, 20.69

66, 15.28

 

0.69 (0.39, 1.24)

.2127

Parkinsonian features, N,%

9, 10.23

39, 8.97

 

0.86 (0.40, 1.86)

.7087

Other neurologic conditions, N,%

17, 20.00

87, 20.67

 

1.04 (0.58, 1.86)

.8908

Medical/metabolic conditions, N,%

80, 90.91

361, 82.61

 

0.48 (0.22, 1.02)

.0574

AD only vs. mixed etiology

56, 63.64

298, 68.04

 

0.82 (0.51, 1.33)

.4225

Living in nursing home, N,%

13, 14.77

85, 19.41

 

1.39 (0.74, 2.62)

.3103

Time since onset of cognitive decline (years)

6.30 ± 3.76

7.81 ± 4.01

1.51

 

.0016

Probable AD diagnosis at baseline

65, 73.86

412, 94.06

 

5.61 (3.02, 10.41)

<.0001

Severity of cognitive impairment

     

MMSE, Mean ± SD

19.46 ± 7.66

12.93 ± 9.03

-6.53

 

<.0001

Normal (>24): N,%

22, 25.00

33, 7.53

 

1.00 (Ref)

 

Mild (21–24): N,%

23, 26.14

67, 15.30

 

1.94 (0.95, 3.98)

.0699

Moderate (10–20): N,%

24, 27.27

136, 31.05

 

3.78 (1.89,7.55)

.0002

Severe (<= 9): N,%

11, 12.5

137, 31.28

 

8.30 (3.67, 18.81)

<.0001

Missing: N,%

8, 9.1

65, 14.84

 

5.42 (2.18, 13.48)

.0003

Functional status

     

Functional activities questionnaire (FAQ), total score, Mean ± SD,

20.96 ± 8.52

24.52 ± 7.10

3.55

 

<.0001

Impaired level of functioning, FAQ > =9, N,%

75, 88.24

405, 95.74

 

3.0 (1.33, 6.75)

.0080

Neuropsychiatric symptoms

     

Neuropsychiatric inventory questionnaire (NPI-Q), total score, Mean ± SD

4.84 ± 4.46

6.18 ± 5.35

1.35

 

.0364

Patients with depression and dysphoria (NPI-Q), N,%

16, 20.25

145, 37.08

 

2.32 (1.29, 4.17)

.0048

Severity level for patients with depression and dysphoria (NPI-Q), Mean ± SD

1.56 ± 0.73

1.40 ± 0.62

-0.16

 

.3276

  1. NOTE: CI = Confidence interval, SD = standard deviation, AD = Alzheimer’s disease; MMSE = Mini Mental Status Examination.